Large-scale testing (Phase 3)UnknownNCT00052156What this trial is testingVaccine Therapy for Patients With Stage IV MelanomaWho this might be right forMalignant Melanoma CancerVax Corporation 670
Testing effectiveness (Phase 2)Study completedNCT00445965What this trial is testingIodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT01245556What this trial is testingSafety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 8
Not applicableStudy completedNCT03707574What this trial is testingGenetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyWho this might be right forAdvanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562129What this trial is testingIL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma PatientsWho this might be right forMelanoma Stage IIIMelanoma Stage IVInoperable Disease H. Lee Moffitt Cancer Center and Research Institute 18
Large-scale testing (Phase 3)Ended earlyNCT01013623What this trial is testingStage IV Surgery Versus Best Medical TherapyWho this might be right forStage IV Resectable Melanoma Saint John's Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00700882What this trial is testingDasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By SurgeryWho this might be right forMelanoma (Skin) Eastern Cooperative Oncology Group 81
Testing effectiveness (Phase 2)Study completedNCT01065441What this trial is testingExperimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV CancerWho this might be right forSolid Tumors Stage II, Stage III and Stage IVBreast CancerColorectal Cancer+5 more Michael Har-Noy 9
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Not applicableUnknownNCT00897481What this trial is testingStudying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node BiopsyWho this might be right forMelanoma (Skin) Leeds Cancer Centre at St. James's University Hospital 1,000
Not applicableStudy completedNCT00897546What this trial is testingBiomarkers to Predict Response to Interferon Therapy in Patients With MelanomaWho this might be right forMelanoma (Skin) ECOG-ACRIN Cancer Research Group 1,716
Testing effectiveness (Phase 2)Ended earlyNCT00675727What this trial is testingSafety Study of CADI-05 in Patients With Advanced Stage MelanomaWho this might be right forStage III or Stage IV Melanoma Cadila Pharnmaceuticals 20
Early research (Phase 1)Study completedNCT00471471What this trial is testingVaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forIntraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin) Ahmad Tarhini 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT02196181What this trial is testingTesting Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has SpreadWho this might be right forStage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7Unresectable Melanoma National Cancer Institute (NCI) 280
Testing effectiveness (Phase 2)Study completedNCT00084656What this trial is testingMonoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) Bristol-Myers Squibb 77
Not applicableLooking for participantsNCT07148245What this trial is testingSymptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous MelanomaWho this might be right forCutaneous MelanomaCutaneous Melanoma, Stage IIICutaneous Melanoma by AJCC V7 Stage+1 more University of California, San Francisco 300
Testing effectiveness (Phase 2)Study completedNCT00669019What this trial is testingSaracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT01005472What this trial is testingTemozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaWho this might be right forMetastatic Melanoma Jonsson Comprehensive Cancer Center 16
Not applicableStudy completedNCT00346008What this trial is testingStudying Genes to Identify Melanoma in Patients in Iceland and Their Family MembersWho this might be right forMelanoma (Skin) Iceland Genomics Corporation 2,500
Testing effectiveness (Phase 2)WithdrawnNCT03220009What this trial is testingNivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWho this might be right forCervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more National Cancer Institute (NCI)